46
Views
87
CrossRef citations to date
0
Altmetric
Article

A Novel Mechanism of Sequestering Fibroblast Growth Factor 2 by Glypican in Lipid Rafts, Allowing Skeletal Muscle Differentiation

&
Pages 1634-1649 | Received 28 Aug 2009, Accepted 14 Jan 2010, Published online: 20 Mar 2023
 

Abstract

Heparan sulfate proteoglycans (HSPGs) are critical modulators of growth factor activities. Skeletal muscle differentiation is strongly inhibited by fibroblast growth factor 2 (FGF-2). We have shown that HSPGs present at the plasma membrane are expressed in myoblasts and are downregulated during muscle differentiation. An exception is glypican-1, which is present throughout the myogenic process. Myoblasts that do not express glypican-1 exhibit defective differentiation, with an increase in the receptor binding of FGF-2, concomitant with increased signaling. Glypican-1-deficient myoblasts show decreased expression of myogenin, the master gene that controls myogenesis, myosin, and the myoblast fusion index. Reversion of these defects was induced by expression of rat glypican-1. Glypican-1 is the only HSPG localized in lipid raft domains in myoblasts, resulting in the sequestration of FGF-2 away from FGF-2 receptors (FGFRs) located in nonraft domains. A chimeric glypican-1, containing syndecan-1 transmembrane and cytoplasmic domains, is located in nonraft domains interacting with FGFR-IV- and enhanced FGF-2-dependent signaling. Thus, glypican-1 acts as a positive regulator of muscle differentiation by sequestering FGF-2 in lipid rafts and preventing its binding and dependent signaling.

We are indebted to David J. Carey (Siegfried and Janet Weiss Center for Research, Danville, PA) and to Ralph D. Sanderson (University of Alabama at Birmingham, AL) for providing anti glypican-1 antibody and pcDNA 3.0-rat-glypican-1, respectively. We thank Juan Larraín and Hugo Olguín (P. Universidad Católica de Chile) for offering encouragement and helpful suggestions.

This study was supported by research grants from FONDAP-Biomedicine (grants 13980001 and CARE PFB 12/2007) and the Muscular Dystrophy Association (grant 89419) as well as by the doctoral fellowship granted to Jaime A. Gutierrez by CONYCYT, Chile.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.